StonvexLoading…
StonvexStonvexStonvexCore line items from FTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $67.57M | $70.05M | $237.26M | $169.74M | $113.71M |
Operating Income | Not available | $7.59M | $23.24M | $17.26M | $8.15M |
Net Income | Not available | $4.66M | $30.53M | $27.50M | $7.15M |
EPS (Diluted) | $0.12 | $0.12 | $0.84 | $0.78 | $0.21 |
Total Assets | Not available | $231.84M | $220.05M | $212.69M | $172.24M |
Total Liabilities | Not available | $113.67M | $106.99M | $102.19M | $100.39M |
Cash & Equivalents | Not available | $5.68M | $5.73M | $4.60M | $5.03M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 36.17M | 30.13M | 29.99M | 29.85M |